Bruker Daltonics has announced a framework agreement with Synlab concerning molecular microbial identification based on MALDI-ToF mass spectrometry. Synlab is a European private diagnostic laboratory association with more than 70 labs, which will be equipped exclusively with Bruker’s MALDI Biotyper system. Bruker and Synlab intend to enlarge and refine the MALDI Biotyper reference library using well-defined clinical isolates from the daily microbial routine work of the Synlab laboratories. www.synlab.de, www.bdal.com/maldibiotyper
Biocius Life Sciences has completed its spin-out from BioTrove Inc. and is an independent company. It now holds all of the intellectual property and technology for the RapidFire mass spectrometry, which integrates sample preparation with mass spectrometry at a rate of up to 6s per sample. www.biocius.com
Chemical studies of exoplanets—planets that orbit not the Sun, but distant stars—rely on spectroscopy. Such studies used to be the domain of space observatories and of the world's largest ground-based telescopes. Now, a new data analysis technique successfully pioneered by a group of astronomers from the US, the UK and Germany has brought exoplanet spectroscopy to a much smaller (and more wide-spread) class of ground-based telescopes.
AB Sciex has been launched as a new company combining the two halves of the AB Sciex mass spectrometry joint venture into an integrated organisation. AB Sciex intends to use its new operating structure to increase speed to market in developing new solutions and expanding service and support to enable the scientific community to continue its increasing use of mass spectrometry for a broader range of applications.
Another of the acquisitions of companies involved in spectroscopy has been receiving attention from the world’s regulators. Following a ruling by the US Federal Trade Commission sale of the Applied Biosystems mass spectrometry business, jointly owned by Life Technologies and MDS Analytical Technologies, looks to be ready to be concluded. The US FTC have required the sale of MDS’s laser microdissection business to ensure competition in the North American market.
Another stumbling block has been litigation by PerkinElmer against MDS, but this has been settled before it was heard in court. MDS have indicated that they hope the sale to be completed by the end of March.
Magnetic resonance (MR) spectroscopy may in the future be able both to pinpoint the precise location of prostate cancer and to determine the tumour's aggressiveness, information that could help guide treatment planning. In Science Translational Medicine (doi: 10.1126/scitranslmed.3000513), Massachusetts General Hospital (MGH) researchers report how spectroscopic analysis of the biochemical makeup of prostate glands accurately identified the location of tissue confirmed to be malignant by conventional pathology.
Children as young as five months old will follow the gaze of an adult towards an object and engage in joint attention, according to research at Birkbeck, University of London, funded by the Wellcome Trust and the Medical Research Council. The findings, published in Biology Letters (doi: 10.1098/rsbl.2009.1069), suggest that the human brain develops this important social skill surprisingly early in infancy.
Researchers at the University of St Andrews have developed a powerful technique that could allow earlier cancer detection. In a joint venture between the Schools of Physics & Astronomy and the Bute Medical School, the St Andrews researchers have advanced new technology that relies on Raman spectroscopy.
The European Commission has cleared, under the EU Merger Regulation, the proposed acquisition of Varian Inc. by Agilent Technologies Inc., both US companies, by way of purchase of shares. The decision is conditional upon the divestment of Agilent's entire micro/portable gas chromatography instrument business and Varian's entire laboratory gas chromatography, triple quadrupole gas chromatography-mass spectrometry and inductively coupled plasma-mass spectrometry instrument businesses. In view of the remedies proposed, the Commission has concluded that the operation would not significantly impede effective competition in the European Economic Area (EEA) or any substantial part of it.
Page 14 of 42
Free print subscription
José Alejandro Hered... saidDear readers,
I wanted to corroborat... 1 month ago
Prof. Dr. Erwin L. Z... saidI, and my research colleagues, are gr... 1 month ago
tesfaye saidthe NIR spectroscopy reduced the cost... 5 months ago
fred isaboke saidWant to inquire about the specificati... 1 year ago
Markus Rupprecht saidDear Tony Davies,
thank you so much f... 1 year ago
- Atomic absorption
- Atomic emission
- Ion mobility
- Laser spectroscopy
- Mass spectrometry
- Near infrared
- NMR ESR EPR
- North America
- Related equipment
- RMs and standards
- Separation science
- South America
- Surface analysis
- X-ray spectrometry